Check out the FAQ,Terms of Service & Disclaimers by clicking the
link. Please register
to be able to post. By viewing this site you are agreeing to our Terms of Service and Acknowledge our Disclaimers.
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
Announcement
Collapse
No announcement yet.
Southern France reports of new variant with 46 mutations
French health authorities have reported the spread of a new SARS-CoV-2 variant B.1.640.2 that possess 46 mutations and 37 deletions including the N501Y and E484K mutations.
As of press time, a total of 67 patients all displaying moderate and severe conditions of the disease and requiring hospitalization have been identified having been infected with the new SARS-Cov-2 variant B.1.640.2 wh...
This article states that 67 patients have been identified with this variant - all suffering moderate to severe symptoms. The variant first came to light at the end of November 2021 with the initial case being from Cameroon.
SARS-CoV-2 variants have become a major virological, epidemiological and clinical concern, particularly with regard to the risk of escape from vaccine-induced immunity. Here we describe the emergence of a new variant. For twelve SARS-CoV-positive patients living in the same geographical area of southeastern France, qPCR testing that screen for variant-associated mutations showed an atypical combination. The index case returned from a travel in Cameroon. The genomes were obtained by next-generation sequencing with Oxford Nanopore Technologies on GridION instruments within ≈8 h. Their analysis revealed 46 mutations and 37 deletions resulting in 30 amino acid substitutions and 12 deletions. Fourteen amino acid substitutions, including N501Y and E484K, and 9 deletions are located in the spike protein. This genotype pattern led to create a new Pangolin lineage named B.1.640.2, which is a phylogenetic sister group to the old B.1.640 lineage renamed B.1.640.1. Both lineages differ by 25 nucleotide substitutions and 33 deletions. The mutation set and phylogenetic position of the genomes obtained here indicate based on our previous definition a new variant we named “IHU”. These data are another example of the unpredictability of the emergence of SARS-CoV-2 variants, and of their introduction in a given geographical area from abroad.
### Competing Interest Statement
DR has a conflict of interest being a consultant for Hitachi High-Technologies Corporation, Tokyo, Japan from 2018 to 2020. All other authors have no conflicts of interest to declare. Funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
### Funding Statement
This work was supported by the French Government under the Investments for the Future program managed by the National Agency for Research (ANR), no. Mediterranee-Infection 10-IAHU-03 Region Provence Alpes Cote d Azur and European funding FEDER PRIMMI (Fonds Europeen de Developpement Regional-Plateformes de Recherche et d Innovation Mutualisees Mediterranee Infection), no. FEDER PA 0000320 PRIMMI Hitachi High-Technologies Corporation, Tokyo, Japan.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of University Hospital Institute Mediterranee Infection gave ethical approval for this work (No. 2021-029).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
All data produced are available online at <https://www.gisaid.org>.
<https://www.gisaid.org>
Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein
Their analysis revealed 46 mutations and 37 deletions resulting in 30 amino acid substitutions and 12 deletions. Fourteen amino acid substitutions, including N501Y and E484K, and 9 deletions are located in the spike protein.
"The only security we have is our ability to adapt."
Covid warning as ANOTHER new variant discovered in France – scientists sound alarm
ANOTHER variant of coronavirus has been detected by experts working in Marseille, France, as the world continues to battle the deadly virus.
The alarm was sounded by experts at the IHU Mediterranee Infection in Marseille. They announced on their Twitter that they had detected a new variant in Covid-19 patients from Forcalquier, in the Alpes-de-Haute-Provence region. Dubbed "IHU," the variant has been registered under the name B.1.640.2 on the GISAID network (Global Initiative on Sharing Avian Influenza Data).
"The only security we have is our ability to adapt."
SARS-CoV-2 B.1.640.2 Variant: Further to our breaking coverage of the new SARS-CoV-2 variant B..640.2 originating from Cameroon and spreading in Southern France, we have got latest updates that the number of cases in Provence-Alpes-Côte region Azure and also in surrounding areas have swelled to 952 cases as of the 1st Of January 2022.(Last update on 13th of Dec by French health authorities w...
Article states 952 cases now detected in France, 17 individuals in the UK confirmed and also Monaco. (Obviously not going to be able to keep a track of the spread in the UK as PCR tests being rationed to conserve the laboratories conducting the analysis).
"The only security we have is our ability to adapt."
A variant found in France is not a concern, the W.H.O. says.
By Shashank Bengali
Jan. 5, 2022
Updated 9:55 a.m. ET
The World Health Organization says that it is monitoring a coronavirus variant detected in a small number of patients in France, but that, for now, there is little reason to worry about its spread.
The B.1.640.2 variant was first identified in October and uploaded to Gisaid, a database for disease variants, on Nov. 4. Only about 20 samples have been sequenced so far, experts said this week, and only one since early December.
Abdi Mahmud, a Covid incident manager with the W.H.O., told reporters in Geneva on Tuesday that the variant had been on the agency’s radar since November, but added that it did not appear to have spread widely over the past two months.
“That virus has had a lot of chances to pick up,” he said.
...
Concerns over the variant in France arose after researchers found that it contained 46 mutations that differed from the original version of the coronavirus. Omicron also has a high number of mutations, which researchers believe made it far more transmissible.
...
Numerous coronavirus variants have emerged over the past two years, and the reasons that some spread widely while others do not are complex. For now, several independent researchers say there is little reason to be concerned about the I.H.U. variant.
...
Four other samples sourced from individuals living in the same region were positive for this variant, taking the tally to 12 till the end of November. The number is not high to cause concern and not sufficient to get details of how transmissible the variant could be or whether it causes disease of higher severity.
...ICU admission rates in the region of France where the variant was found had increased which could be a cause of concern. However, the new variant would have to be much more transmissible to have a global impact, given that Omicron spreads faster than Delta.
A COVID warning has been issued for Britons as a new variant of the virus with "46 mutations" has already been found in the UK, Express.co.uk can confirm.
Dubbed the IHU variant, its official name is B.1.640.2 and Express.co.uk can confirm there have been at least two cases "already in the UK," but experts are monitoring it closely.
The UK Health Security Agency (UKHSA) commented: "We are aware of a small number of cases of B.1.640 in the UK and have been monitoring this particular variant specifically since late October.
"As it is in the nature of viruses to mutate often and at random, it is not unusual for small numbers of cases to arise featuring new sets of mutations.
At the present time, it has not been designated a Variant Under Investigation or a Variant of Concern
.
"The only security we have is our ability to adapt."
Covid-19: B.1.640.2, better known as an “IHU variant”, is a “variant under surveillance”
Lalaina Andriamparany
January 10, 2022
A variant of Covid-19 was recently discovered by researchers at the IHU in Marseille. This is a mutation that remains under surveillance according to the World Health Organization. B.1.640.2 (more colloquially referred to as "IHU variant") is believed to originate from Cameroon. In an interview with DW, Professor Yap Boum, Cameroonian epidemiologist and founder of Epicenter for Africa, sheds light on the progress of local research.
Sequencing work in progress
Despite the recent discovery of this variant, the media hastened to talk about the B.1.640.2 detected in the south of France by the University Hospital Institute ( IHU ) in Marseille, in an individual returning from Cameroon.
The IHU researchers have already published an article on medRxiv , which is awaiting its peer review, " but which has a result which may be interesting ", according to Professor Yap Boom.
In Cameroon , we are mobilizing resources to quickly obtain local sequences and find out if the IHU virus is really circulating in the country.
...
However, Professor Yap Boum, as an epidemiologist , wishes to clarify the limits of such a process at such an early stage. “ We still need to have confirmations. We hope that in the coming weeks, we will be able to have confirmation of the variants in circulation in Cameroon. It's a matter of patience, in a few days we will be able to have more details. "
In addition, it is still difficult to give a definitive opinion on the various symptoms that the variant causes. In fact, we speak of a “variant” when the virus goes through several mutations. In this sense, the fact of finding its presence in a single person does not allow us to study it or to know whether it generates a severe form or not. Conversely, the Marseille IHU is one of the places in the world where the most research has been done on COVID-19. And we are able to compare this variant to its predecessors.
Comment